// App-Quantinova.ai

: Incidence of Acute Graft-Versus-Host Disease and Survival after Allogeneic Hematopoietic Cell Transplantation over Time: A Study from the Transplant Complications and Chronic Malignancies Working Party of the EBMT

Researchers

Presenter

  • Hildegard T. Greinix

Principal Investigators

  • Linda Koster

  • Olaf Penack

  • Ibrahim Yakoub-Agha

  • Silvia Montoto

  • Christian Chabannon

  • Jan Styczynski

  • Arnon Nagler

  • Marie Robin

  • Stephen Robinson

  • Yves Chalandon

  • Malgorzata Mikulska

  • Stefan Schnland

  • Zinaida Peric

  • Annalisa Ruggeri

  • Francesco Lanza

  • Mohamad Mohty

  • Grzegorz W Basak

  • Kroger Nicolaus

Medical Centers

  • Department of Medicine, Division of Haemotology, Medical University of Graz, Graz, AUT

  • EBMT Registry Office, Leiden, Netherlands

  • EBMT Data Office Leiden,, Leiden,, Netherlands

  • Department Hematology, Oncology and Tumor Immunology, Charite University Hospital, Berlin, Germany

  • Inserm U995, LIRIC, Lille University, Department of Hematology, Lille University Hospital, Lille, France

  • St. Bartholomew`s and The Royal London NHS Trust, London, United Kingdom

  • Institut Paoli-Calmettes, Marseille, France

  • Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland

  • Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel

  • Hematology/Transplantation, Hospital Saint Louis, Paris, France

  • Bristol Oncology, Bristol, United Kingdom

  • Département d’Oncologie, Service d’Hématologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland

  • Division of Infectious Diseases, University of Genova, Ospedale Policlinco San Martino, Genova, Italy

  • Medizinische Klinik V and Amyloidosis Center, Universitätsklinikum Heidelberg, Heidelberg, Germany

  • Univeristy Hospital Centre Zagreb, Zagreb, Croatia

  • Department of Pediatric Hematology and Oncology, IRCCS Bambino Gesù Children's Hospital, Paris, France

  • Ravenna Hospital, Ravenna, Italy

  • Hematology Department, Hopital Saint Antoine, Service dHematologie et Therapie Cellulaire, Paris, France

  • Department of Haematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland

  • University Hospital Eppendorf Frauenklinik, Hamburg, Germany

Locations

  • Netherlands

  • Germany

  • France

  • United Kingdom

  • Poland

  • Israel

  • Switzerland

  • Italy

  • Croatia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Graft-versus-host disease

Biomarkers

  • Hematocrit

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved